{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:55:40Z","timestamp":1791255340611,"version":"4.1.0"},"reference-count":55,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T00:00:00Z","timestamp":1434931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The growing resistance to current antimalarial drugs is a major concern for global public health. The pressing need for new antimalarials has led to an increase in research focused on the Plasmodium parasites that cause human malaria. Thioredoxin reductase (TrxR), an enzyme needed to maintain redox equilibrium in Plasmodium species, is a promising target for new antimalarials. This review paper provides an overview of  the structure and function of TrxR, discusses similarities and differences between the thioredoxin reductases (TrxRs) of different Plasmodium species and the human forms of the enzyme, gives an overview of modeling Plasmodium infections in animals, and suggests the role of Trx functions in antimalarial drug resistance. TrxR of Plasmodium falciparum is a central focus of this paper since it is the only Plasmodium TrxR that has been crystallized and P. falciparum is the species that causes most malaria cases. It is anticipated that the information summarized here will give insight and stimulate new directions in which research might be most beneficial.<\/jats:p>","DOI":"10.3390\/molecules200611459","type":"journal-article","created":{"date-parts":[[2015,6,22]],"date-time":"2015-06-22T12:06:06Z","timestamp":1434974766000},"page":"11459-11473","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery"],"prefix":"10.3390","volume":"20","author":[{"given":"Sara","family":"McCarty","sequence":"first","affiliation":[{"name":"College of Sciences and Mathematics, Auburn University, Auburn, AL 36849, USA"},{"name":"Department of Drug Discovery and Development, Harrison School of Pharmacy,  Auburn University, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Schellenberger","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Development, Harrison School of Pharmacy,  Auburn University, Auburn, AL 36849, USA"},{"name":"College of Agriculture, Auburn University, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Goodwin","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngolui","family":"Fuanta","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Auburn University, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Tekwani","sequence":"additional","affiliation":[{"name":"National Center for Natural Products Research and Department of BioMolecular Sciences,  School of Pharmacy, University of Mississippi, Oxford, MS 38677, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Calder\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Drug Discovery and Development, Harrison School of Pharmacy,  Auburn University, Auburn, AL 36849, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,6,22]]},"reference":[{"key":"ref_1","unstructured":"Malaria, Available online:http:\/\/www.cdc.gov\/malaria\/about\/faqs.html."},{"key":"ref_2","unstructured":"Malaria. Available online:http:\/\/www.who.int\/mediacentre\/factsheets\/fs094\/en\/."},{"key":"ref_3","unstructured":"World Malaria Report 2014. Available online:http:\/\/apps.who.int\/iris\/bitstream\/10665\/144852\/2\/9789241564830_eng.pdf?ua=1."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/ng.2375","article-title":"Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade","volume":"44","author":"Tachibana","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_5","unstructured":"Treatment of Malaria: Guideline for Clinicians (United States), Available online:http:\/\/www.cdc.gov\/malaria\/diagnosis_treatment\/clinicians2.html."},{"key":"ref_6","unstructured":"Life Cycle. Available online:http:\/\/www.bio.davidson.edu\/people\/sosarafova\/Assets\/Bio307\/ruturakhia\/page01.html."},{"key":"ref_7","unstructured":"Crutcher, J.M., and Hoffman, S.L. (1996). Medical Microbiology, Available online:http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK8584\/."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijmm.2012.07.007","article-title":"Thioredoxin and glutathione systems in Plasmodium falciparum","volume":"302","author":"Jortzik","year":"2012","journal-title":"Int. J. Med. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1046\/j.1432-1327.2000.01701.x","article-title":"Physiological functions of thioredoxin and thioredoxin reductase","volume":"267","author":"Holmgren","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/AAC.03274-14","article-title":"Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model","volume":"59","author":"Lakshminarayana","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF01289412","article-title":"Thioredoxin and glutathione system of malaria parasite Plasmodium falciparum","volume":"217","author":"Gilberger","year":"2001","journal-title":"Protoplasma"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s00018-002-8484-9","article-title":"The thioredoxin system of Plasmodium falciparum and other parasites","volume":"59","author":"Rahlfs","year":"2002","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1179\/135100003225002844","article-title":"Plasmodium falciparum thioredoxins and glutaredoxins as central players in redox metabolism","volume":"8","author":"Rahlfs","year":"2003","journal-title":"Redox Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.2174\/0929867321666131201144612","article-title":"The redox systems of Plasmodium falciparum and Plasmodium vivax: Comparison, in silico analyses and inhibitor studies","volume":"15","author":"Mohring","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/biof.5520270110","article-title":"The thiol-based redox networks of pathogens: Unexploited targets in the search for new drugs","volume":"27","author":"Jaeger","year":"2006","journal-title":"BioFactors"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1046\/j.1432-1327.2000.01702.x","article-title":"Thioredoxin reductase two modes of catalysis have evolved","volume":"267","author":"Williams","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1046\/j.1432-1327.2000.01703.x","article-title":"Thioredoxin reductase as a pathophysiological factor and drug target","volume":"267","author":"Becker","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S1471-4922(03)00141-7","article-title":"Thiol-based redox metabolism of protozoan parasites","volume":"19","author":"Liebau","year":"2003","journal-title":"Trends Parasitol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14786419.2013.866112","article-title":"Determination of antiplasmodial activity and binding affinity of curcumin and demethoxycurcumin towards PfTrxR","volume":"28","author":"Munigunti","year":"2014","journal-title":"Nat. Prod. Res."},{"key":"ref_20","first-page":"1135","article-title":"Determination of antiplasmodial activity and binding affinity of selected natural products towards PfTrxR and PfGR","volume":"8","author":"Munigunti","year":"2013","journal-title":"Nat. Prod. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.bmcl.2006.01.027","article-title":"Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents","volume":"16","author":"Andricopulo","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbrc.2012.07.156","article-title":"Crystal Structure of Plasmodium falciparum thioredoxin reductase, a validated drug target","volume":"425","author":"Boumis","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1016\/j.jmb.2013.06.037","article-title":"Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex","volume":"425","author":"Jortzik","year":"2013","journal-title":"Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1021\/bi400931k","article-title":"A mechanistic investigation of the c-terminal redox motif of thioredoxin reductase from Plasmodium falciparum","volume":"53","author":"Snider","year":"2014","journal-title":"Biochemistry"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"29584","DOI":"10.1074\/jbc.272.47.29584","article-title":"Identification and characterization of the functional amino acids at the active site of the large thioredoxin reductase from Plasmodium falciparum","volume":"272","author":"Gilberger","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/135100003225002853","article-title":"Thioredoxin reductase and glutathione synthesis in Plasmodium falciparum","volume":"8","author":"Muller","year":"2003","journal-title":"Redox Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"32967","DOI":"10.1074\/jbc.M601141200","article-title":"Identification of acid-base catalytic residues of high-Mr thioredoxin reductase from Plasmodium falciparum","volume":"281","author":"McMillan","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1475-2875-3-23","article-title":"Antioxidant defense in Plasmodium falciparum\u2014Data mining of the transcriptome","volume":"3","author":"Bozdech","year":"2004","journal-title":"Malar. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1432-1327.1999.00286.x","article-title":"Human mitochondrial thioredoxin reductase","volume":"261","author":"Damdimopoulos","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"26491","DOI":"10.1074\/jbc.M503638200","article-title":"Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation","volume":"280","author":"Su","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1039\/C4OB02459A","article-title":"Uncovering new structural insights for antimalarial activity from cost-effective aculeatin-like derivatives","volume":"13","author":"Winkler","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1021\/bi3005076","article-title":"Discovery and biochemical characterization of Plasmodium thioredoxin reductase inhibitor from an antimalarial set","volume":"51","author":"Theobald","year":"2012","journal-title":"Biochemistry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"37388","DOI":"10.1074\/jbc.M110.123323","article-title":"Molecular genetics evidence for the in vivo roles of the two major NADPH-dependent disulfide reductases in the malaria parasite","volume":"285","author":"Buchholz","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2958.2011.07933.x","article-title":"Dissecting the role of glutathione biosynthesis in Plasmodium falciparum","volume":"83","author":"Patzewitz","year":"2012","journal-title":"Mol. Microbiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1389203715666140530091910","article-title":"Thioredoxin reductase and its inhibitors","volume":"15","author":"Saccoccia","year":"2014","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1365-2958.2006.05303.x","article-title":"Structural and biochemical characterization of a mitochondrial peroxiredoxin from Plasmodium falciparum","volume":"61","author":"Boucher","year":"2006","journal-title":"Mol. Microbiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"25970","DOI":"10.1074\/jbc.M203539200","article-title":"Thioredoxin reductase is essential for the survival of Plasmodium falciparum erythrocytic stages","volume":"277","author":"Krnajski","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_38","first-page":"7","article-title":"Screening of antimalarial drugs: An overview","volume":"38","author":"Kaira","year":"2006","journal-title":"Indian J. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0169-4758(95)80088-3","article-title":"A mouse model for human malaria erythrocytic stages","volume":"11","author":"Badell","year":"1995","journal-title":"Parasitol. Today"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: Efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1128\/AAC.45.6.1847-1853.2001","article-title":"Human malaria n immunocompromised mice: New in vivo model for chemotherapy studies","volume":"45","author":"Moreno","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/00034983.1977.11687206","article-title":"The chemotherapy of rodent malaria. XXVI. Studies on mefloquine (WR 142,490)","volume":"71","author":"Peters","year":"1977","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/00034983.1987.11812165","article-title":"The chemotherapy of rodent malaria. XLII. Halofantrine and halofantrine resistance","volume":"81","author":"Peters","year":"1987","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1021\/jm0000766","article-title":"Synthesis and antimalarial activity of sixteen dispiro-1,2,4,5-tetraoxanes: Alkyl-substituted 7,8,15,16-tetraoxadispiro[5.2.5.2]hexadecanes","volume":"43","author":"Vennerstrom","year":"2000","journal-title":"J. Med. Chem."},{"key":"ref_45","unstructured":"Moll, K., Ljungstr\u04e7m, I., Perlmann, H., Scherf, A., and Wahlgren, M. (2008). Methods in Malaria Research, Malaria Research and Reference Reagent Resource Center. [5th ed.]."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/1475-2875-13-414","article-title":"In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine","volume":"13","author":"Sahu","year":"2014","journal-title":"Malar. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4269\/ajtmh.2012.11-0552","article-title":"Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances","volume":"86","author":"Deye","year":"2012","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1051\/parasite\/2014059","article-title":"Challenges of drug-resistant malaria","volume":"21","author":"Sinha","year":"2014","journal-title":"Parasite"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/ars.2012.4625","article-title":"Glutathione transport: A new role for PfCRT in chloroquine resistance","volume":"19","author":"Patzewitz","year":"2013","journal-title":"Antioxid Redox Signal."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1074\/jbc.M806944200","article-title":"Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione","volume":"284","author":"Raj","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2015.01.014","article-title":"The overexpression and nuclear translocation of Trx-1 during hypoxia confers on HepG2 cells resistance to DDP, and GL-V9 reverses the resistance by suppressing the Trx-1\/Ref-1 axis","volume":"82","author":"Zhao","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2013.03.014","article-title":"2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage","volume":"707","author":"Zhou","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e48175","DOI":"10.1371\/journal.pone.0048175","article-title":"Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism","volume":"7","author":"Sobhakumari","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/jac\/dkr192","article-title":"Pyruvate:ferredoxin oxidoreductase and thioredoxin reductase are involved in 5-nitroimidazole activation while flavin metabolism is linked to 5-nitroimidazole resistance in Giardia lamblia","volume":"66","author":"Leitsch","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.freeradbiomed.2009.09.016","article-title":"High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy","volume":"47","author":"Eriksson","year":"2009","journal-title":"Free Radic. Biol. Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/20\/6\/11459\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:48:13Z","timestamp":1760215693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/20\/6\/11459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,22]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6]]}},"alternative-id":["molecules200611459"],"URL":"https:\/\/doi.org\/10.3390\/molecules200611459","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,22]]}}}